Viridian Therapeutics
Price & Volume
Stats
See more52W Range | $13.18-$34.29 |
Market Cap | $2B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $71.1M |
Revenue Growth (YoY) | 278.7% |
Gross Profit (12 Mos) | -$253.5M |
Diluted EPS | -$3.39 |
News
See moreYahoo Finance • last month
Viridian Metals Announces Closing of Non-Brokered Private Placement and Market Making Agreement with Independent Trading Group
Yahoo Finance • 2 months ago
Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending
Yahoo Finance • 3 months ago
Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN)
Yahoo Finance • 3 months ago
Wedbush Sees Commercial Edge for Viridian (VRDN) After FDA Milestone
About
CEO | Mr. Stephen F. Mahoney J.D., MBA |
Address | 221 Crescent Street, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 252 |